Clinical Trials on Neuroendocrine Tumor Grade 1 in United States
Total 2893 results
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI)TerminatedRecurrent Childhood Medulloblastoma | Childhood Choroid Plexus Tumor | Childhood Ependymoblastoma | Childhood Grade III Meningioma | Childhood High-grade Cerebellar Astrocytoma | Childhood High-grade Cerebral Astrocytoma | Childhood Medulloepithelioma | Recurrent Childhood Anaplastic Astrocytoma | Recurrent... and other conditionsUnited States
-
Jona Hattangadi-GluthRecruitingGlioma | Meningioma | Primary Brain Tumor | SchwannomaUnited States
-
Fox Chase Cancer CenterMerck Sharp & Dohme LLCCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Small Lymphocytic LymphomaUnited States
-
Children's Hospital Medical Center, CincinnatiTerminatedGlioblastoma Multiforme (WHO Grade IV) | Anaplastic Astrocytoma (WHO Grade III)United States
-
Baylor College of MedicineCancer Prevention Research Institute of Texas; The Methodist Hospital Research... and other collaboratorsActive, not recruitingRefractory Neuroblastoma | Uveal Melanoma | Relapsed Ewing Sarcoma | Relapsed Osteosarcoma | Relapsed Neuroblastoma | Relapsed Rhabdomyosarcoma | Phyllodes Breast TumorUnited States
-
Monte Rosa Therapeutics, IncRecruitingNSCLC | Prostate Cancer | SCLC | DLBCL | High Grade Neuroendocrine Cancer | L-MYC and N-MYC Amplified Solid Tumors | NSCLC With High or Low L-MYC or N-MYC Expression | HR-positive, HER2-negative Breast CancerUnited States, Canada
-
TerSera Therapeutics LLCCompletedCarcinoid SyndromeUnited States
-
IpsenTerminatedNeuroendocrine TumoursUnited Kingdom, France, Germany, Australia, Italy
-
National Cancer Institute (NCI)RecruitingAdvanced Extrapulmonary Neuroendocrine Carcinoma | Metastatic Extrapulmonary Neuroendocrine Carcinoma | Recurrent Extrapulmonary Neuroendocrine Carcinoma | Unresectable Extrapulmonary Neuroendocrine CarcinomaUnited States
-
Heather WachtelRecruitingPheochromocytoma | ParagangliomaUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
Incyte CorporationActive, not recruitingMetastatic Merkel Cell CarcinomaUnited Kingdom, United States, Germany, Canada, Czechia, Italy, France, Spain, Switzerland, Australia, Poland, Hungary
-
TriHealth Inc.TriHealth Cancer Institute; TriHealth Surgical Institute; TriHealth Ultrasound... and other collaboratorsWithdrawnMelanoma (Skin) | Tumor Skin | BRAF Gene Mutation | Melanoma Stage IIIb-IVM1a | Metastasis SkinUnited States
-
University of California, San FranciscoCompletedPheochromocytoma | ParagangliomaUnited States
-
IpsenCompletedMidgut Neuroendocrine Tumours | Pancreatic TumoursSpain, United Kingdom, Denmark, Belgium, Germany, France, Netherlands, Ireland, Italy, Poland
-
Novartis PharmaceuticalsCompletedAdvanced Neuroendocrine Tumors of Pancreatic OriginCanada, France, United Kingdom, Taiwan, Belgium, Spain, Netherlands, United States, Italy, Sweden, Switzerland, Thailand, Germany, Greece, Korea, Republic of, Japan, Brazil, Slovakia
-
Novartis PharmaceuticalsRecruitingMelanoma | Solid Tumor | High Grade Glioma | Non Small Cell Lung Cancer | Rare CancersSpain, Germany, United States, Argentina, Austria, Denmark, France, Hungary, Netherlands, China, Japan, Thailand
-
Innovative Surgical DesignsSuspendedLumbar Spinal Stenosis | Spondylolisthesis, Grade 1 | Neurogenic ClaudicationUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Childhood Ependymoma | Recurrent Neuroblastoma | Recurrent Osteosarcoma | Recurrent Childhood Rhabdomyosarcoma | Recurrent Renal Cell Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Recurrent Childhood Soft Tissue Sarcoma | Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGlioblastoma | Malignant Glioma | WHO Grade III Glioma | Metastatic Malignant Neoplasm in the Brain | Low Grade Glioma | PartnerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Grade 3a Follicular LymphomaUnited States
-
BioMimetix JV, LLCNational Cancer Institute (NCI); Duke Cancer InstituteActive, not recruitingGlioblastoma | High Grade Glioma | Astrocytoma, Grade IIIUnited States
-
National Cancer Institute (NCI)RecruitingSmall Cell Lung Cancer | Non-Small Cell Lung Cancer | Extrapulmonary Small Cell Cancer | Pulmonary Neuroendocrine Tumors | Thymic Epithelial TumorsUnited States
-
Case Comprehensive Cancer CenterTerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Novartis; Dana-Farber Cancer InstituteCompletedNeuroendocrine TumorsUnited States
-
IpsenTerminatedMalignant Carcinoid SyndromeUnited States
-
Wenzel SpineCompletedIntervertebral Disc Displacement | Intervertebral Disc Degeneration | Spondylolisthesis, Grade 1 | Prolapsed Lumbar Disc | Prolapsed Cervical DiscUnited States
-
Imperial College LondonRecruitingGlioma | Meningioma | Brain Metastases | Schwannoma | Brain TumourUnited Kingdom
-
M.D. Anderson Cancer CenterRecruitingRenal Medullary Carcinoma | CarcinomasUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular... and other conditionsUnited States
-
Washington University School of MedicineTyrogenexTerminatedAdenocarcinoma | Pancreatic NeoplasmsUnited States
-
University of California, Los AngelesCompleted
-
Sue O'DorisioAdvanced Accelerator ApplicationsWithdrawnNeuroendocrine Tumors | Pheochromocytoma | ParagangliomaUnited States
-
University of California, San FranciscoApproved for marketingPheochromocytoma | ParagangliomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI)RecruitingRefractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy | MSI-H TumorsUnited States
-
National Cancer Institute (NCI)RecruitingAdvanced Solid Tumors | SCLC | HRD CancerUnited States
-
Radiomedix, Inc.Orano Med LLCRecruitingNeuroendocrine TumorsUnited States
-
Novartis PharmaceuticalsCompletedNeoplasms | Kidney Neoplasms | Breast Neoplasms | Pancreatic Neuroendocine Neoplasms (pNETs)France, Germany, United States, Netherlands, Italy, Spain, United Kingdom, Hong Kong, Hungary
-
Loyola UniversityNational Cancer Institute (NCI)RecruitingMelanomaUnited States
-
Vanderbilt-Ingram Cancer CenterRecruiting
-
Dana-Farber Cancer InstituteActive, not recruiting
-
Zarour, Hassane, MDMerck Sharp & Dohme LLCActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterUniversity of British Columbia; San Diego State University; Stony Brook UniversityActive, not recruitingMelanomaUnited States
-
Massachusetts General HospitalIncyte CorporationTerminated
-
University of Colorado, DenverCompletedMelanomaUnited States
-
University of California, DavisAmgenSuspended
-
Memorial Sloan Kettering Cancer CenterSchering-PloughCompleted
-
Jason J. Luke, MDBristol-Myers SquibbActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterRockefeller UniversityCompleted